• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆汁性肝硬化的血清肝纤维化标志物。

Serum surrogate markers of liver fibrosis in primary biliary cirrhosis.

机构信息

University Hospital Department of Gastroenterology, University of Crete, Faculty of Medicine, Heraklion, 71100, Crete, Greece.

出版信息

Eur J Intern Med. 2011 Feb;22(1):77-83. doi: 10.1016/j.ejim.2010.10.002. Epub 2010 Nov 13.

DOI:10.1016/j.ejim.2010.10.002
PMID:21238899
Abstract

BACKGROUND

Hyaluronan, leptin, laminin and collagen IV have been used extensively for the assessment of liver fibrosis. The aim of this study was to assay these markers in the peripheral and hepatic vein blood of primary biliary cirrhosis (PBC) patients and to study their ability to discriminate early from advanced disease.

METHODS

Sera from 62 PBC patients were compared to 60 controls, 44 chronic Hepatitis C, 38 hepatocellular carcinoma and 34 viral cirrhosis patients. Serum from the hepatic vein of 15 cirrhotic PBC patients and 17 patients with viral cirrhosis was also assayed.

RESULTS

All disease groups had significantly increased levels of hyaluronan and collagen IV, compared to controls, while laminin was significantly increased only in viral cirrhosis. Hyaluronan levels were statistically different between early (54.5 ng/ml; 95%CI 27.3-426.9) and late PBC (154.5 ng/ml; 95%CI 55.3-764.4, p<0.05). The area under the curve (AUC) for the identification of late PBC was 0.74 for hyaluronan, 0.63 for leptin, 0.59 for laminin and 0.70 for collagen IV. Hyaluronan had high sensitivity and NPV in identifying late stages of PBC (96% and 90%, respectively). Short term UDCA had no effect on these markers.

CONCLUSION

No single measurement can differentiate between advanced and early fibrosis in PBC. However serum hyaluronan is a promising single serum marker for longitudinal studies in PBC.

摘要

背景

透明质酸、瘦素、层粘连蛋白和胶原 IV 已广泛用于评估肝纤维化。本研究的目的是检测原发性胆汁性肝硬化(PBC)患者外周静脉和肝静脉血中的这些标志物,并研究它们区分早期和晚期疾病的能力。

方法

将 62 例 PBC 患者的血清与 60 例对照、44 例慢性丙型肝炎、38 例肝细胞癌和 34 例病毒性肝硬化患者的血清进行比较。还检测了 15 例肝硬化 PBC 患者和 17 例病毒性肝硬化患者的肝静脉血清。

结果

与对照组相比,所有疾病组的透明质酸和胶原 IV 水平均显著升高,而层粘连蛋白仅在病毒性肝硬化中显著升高。早期(54.5ng/ml;95%CI 27.3-426.9)和晚期 PBC(154.5ng/ml;95%CI 55.3-764.4,p<0.05)患者的透明质酸水平存在统计学差异。透明质酸识别晚期 PBC 的曲线下面积(AUC)为 0.74,瘦素为 0.63,层粘连蛋白为 0.59,胶原 IV 为 0.70。透明质酸在识别 PBC 晚期阶段时具有高灵敏度和阴性预测值(分别为 96%和 90%)。短期 UDCA 对这些标志物没有影响。

结论

没有单一的测量方法可以区分 PBC 的晚期和早期纤维化。然而,血清透明质酸是 PBC 纵向研究的一种很有前途的单一血清标志物。

相似文献

1
Serum surrogate markers of liver fibrosis in primary biliary cirrhosis.原发性胆汁性肝硬化的血清肝纤维化标志物。
Eur J Intern Med. 2011 Feb;22(1):77-83. doi: 10.1016/j.ejim.2010.10.002. Epub 2010 Nov 13.
2
[The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].[血清透明质酸、IV型胶原7S结构域及AST/ALT比值作为慢性乙型肝炎和肝硬化患者肝纤维化标志物的诊断价值]
Taehan Kan Hakhoe Chi. 2003 Jun;9(2):79-88.
3
Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.血清透明质酸和层粘连蛋白作为肝纤维化的生物标志物。
J Gastrointestin Liver Dis. 2010 Jun;19(2):169-74.
4
[Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].[血清透明质酸、IV型胶原和层粘连蛋白水平联合检测在肝纤维化诊断中的价值]
Hunan Yi Ke Da Xue Xue Bao. 2002 Feb 28;27(1):67-8.
5
[Influence of interferon alpha on the serum fibrosis markers of chronic hepatitis C patients].
Zhonghua Gan Zang Bing Za Zhi. 2003 Oct;11(10):622-3.
6
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.熊去氧胆酸治疗的原发性胆汁性肝硬化患者肝纤维化和淋巴细胞性碎屑样坏死的生化标志物
Liver Int. 2004 Jun;24(3):187-93. doi: 10.1111/j.1478-3231.2004.0918.x.
7
[Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].[慢性乙型肝炎患者代偿期肝硬化无创诊断标志物的筛查与评估]
Zhonghua Gan Zang Bing Za Zhi. 2003 Apr;11(4):225-7.
8
[Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].[IV型胶原和透明质酸在丙型肝炎患者血清中对肝纤维化分期的诊断意义]
Ter Arkh. 2005;77(4):50-5.
9
[Diagnostic value of five serum markers for liver fibrosis].[五种血清标志物对肝纤维化的诊断价值]
Zhonghua Gan Zang Bing Za Zhi. 2001 Jun;9(3):148-50.
10
The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.肝纤维化分期与血清生化水平之间的关系
Hepatobiliary Pancreat Dis Int. 2002 May;1(2):246-8.

引用本文的文献

1
Leptin/Melanocortin Pathway in Cholelithiasis Patients: A Diagnostic Perspective.胆结石患者中的瘦素/黑皮质素通路:诊断视角
Protein Pept Lett. 2025;32(1):75-83. doi: 10.2174/0109298665343979241025114114.
2
Leptin Enhances Hepatic Fibrosis and Inflammation in a Mouse Model of Cholestasis.瘦素增强胆汁淤积小鼠模型的肝纤维化和炎症。
Am J Pathol. 2022 Mar;192(3):484-502. doi: 10.1016/j.ajpath.2021.11.008. Epub 2021 Dec 8.
3
The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis.
瘦素和脂联素与肝细胞癌风险和预后的关联:传统荟萃分析、生存分析和剂量反应荟萃分析的结合。
BMC Cancer. 2020 Nov 30;20(1):1167. doi: 10.1186/s12885-020-07651-1.
4
Evolving liver inflammation in biochemically normal individuals with anti-mitochondria antibodies.抗线粒体抗体阳性的生化指标正常个体中不断演变的肝脏炎症
Auto Immun Highlights. 2019 Oct 31;10(1):10. doi: 10.1186/s13317-019-0120-x. eCollection 2019 Dec.
5
Biomarkers for primary biliary cholangitis: current perspectives.原发性胆汁性胆管炎的生物标志物:当前观点
Hepat Med. 2018 Jun 18;10:43-53. doi: 10.2147/HMER.S135337. eCollection 2018.
6
Recent advances in the diagnosis and treatment of primary biliary cholangitis.原发性胆汁性胆管炎诊断与治疗的最新进展
World J Hepatol. 2016 Nov 28;8(33):1419-1441. doi: 10.4254/wjh.v8.i33.1419.
7
Primary biliary cirrhosis: From bench to bedside.原发性胆汁性肝硬化:从实验室到临床
World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):32-58. doi: 10.4292/wjgpt.v6.i3.32.
8
Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial.牛磺熊去氧胆酸治疗肝硬化的疗效与安全性:一项双盲随机对照试验
J Huazhong Univ Sci Technolog Med Sci. 2013 Apr;33(2):189-194. doi: 10.1007/s11596-013-1095-x. Epub 2013 Apr 17.